ERBB2 and neoplasm: Overall, the level of anti-HER-2 antibodies detected in the serum of mice previously treated with CTX + ACT/IS experiencing tumor remission was significantly higher (p<0.001 Mann Whitney) than the amount found in tumor-bearing untreated mice (Figure 4A).